Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (4): 113-116.doi: 10.6040/j.issn.1671-7554.0.2020.1529

Previous Articles     Next Articles

A case of congenital disorder of glycosylation caused by SLC35A2 gene mutation

SUN Yu, CHEN Na, MA Aihua   

  1. Department of Pediatric Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University;
    Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China
  • Published:2021-04-30

PDF (PC)

372

Abstract: Objective To explore the clinical manifestations and genetic basis of a patient with recurrent epileptic seizures and global developmental delay. Methods The clinical data and genetic test results of the patient were analyzed retrospectively and related literature was reviewed. Results The patient, a boy, whose main clinical features were recurrent epileptic seizures and developmental delay that started from about 1 month after birth. Physical examination showed hypopigmentation on the lower abdomen, right leg and back. Video electroencephalogram(EEG)suggested abnormal infant electroencephalogram, periodic burst inhibition with hypsarrhythmia; cerebral magnetic resonance imaging(MRI)indicated abnormal signal in the bilateral periventricular white matter. Next generation sequencing detected that the patient carried a heterozygous de novo mutation of c.262G>C(P.A88P)in SLC35A2 gene(NM_001042498), which was a spontaneous mutation. After use of antiepileptic drugs such as topiramate, clonazepam, levetiracetam and lamotrigine and treatment with adrenocorticotropic hormone(ACTH)in combination, the seizure frequency was decreased. Conclusion SLC35A2-CDG is a metabolic disease caused by X-linked dominant inheritance of glycoprotein synthesis defects. Currently there is no effective treatment and the suspected cases can get a definite diagnosis by gene detection.

Key words: Congenital disorder of glycosylation, SLC35A2 gene, Gene mutation, Epilepsy, Developmental delay

CLC Number: 

  • R729
[1] Jaeken J, Vanderschueren-lodeweyckx M, Casaer P, et al. Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome? [J]. Pediatr Res, 1980, 14(2): 179-179.
[2] Kodera H, Nakamura K, Osaka H, et al. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy [J]. Hum Mutat, 2013, 34(12): 1708-1714.
[3] Witters P, Shawn T, Barone R, et al. Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG[J]. Genet Med, 2020, 22(6): 1102-1107.
[4] Vals M, Angel A, Pilvi I, et al. Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients [J]. J Inherit Metab Dis, 2019, 42(3): 553-564.
[5] Miyamoto S, Mitsuko N, Ohashi T, et al. A case of de novo splice site variant in SLC35A2 showing developmental delays, spastic paraplegia, and delayed myelination [J]. Mol Genet Genomic Med, 2019, 7(8): e814. doi: 10.1002/mgg3.814.
[6] Michelle D, Ilaria G, Deguzman C, et al. Diagnostic yield and treatment impact of targeted exome sequencing in early-onset epilepsy[J]. Front Neurol, 2019, 10: 434. doi: 10.3389/fneur.2019.00434.
[7] Ng BG, Paulina S, Satish A, et al. SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals [J]. Hum Mutat, 2019, 40(7): 908-925.
[8] Yates TM, Suri M, Archana D, et al. SLC35A2-related congenital disorder of glycosylation: Defining the phenotype [J]. EEur J Paediatr Neurol, 2018, 22(6): 1095-1102.
[9] Andrew NH, Bevilacqua J, Shankar K, et al. Retrospective genotype-phenotype analysis in a 305 patient cohort referred for testing of a targeted epilepsy panel[J]. Epilepsy Res, 2018, 144(144): 53-61.
[10] Kristen W, Kyriakie S, Speltz LC, et al. Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report [J]. BMC Med Genet, 2018, 19(1): 100.
[11] Kimizu T, Takahashi Y, Taikan O, et al. A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy [J]. Brain Dev, 2017, 39(3): 256-260.
[12] Fátima L, Barbosa M, Ameur A, et al. Identification of novel genetic causes of Rett syndrome-like phenotypes [J]. J Med Genet, 2016, 53(3): 190-199.
[13] Doerre K, Olczak M, Wada Y, et al. A new case of UDP-galactose transporter deficiency(SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach [J]. J Inherit Metab Dis, 2015, 38(5): 931-940.
[14] Hino-fukuyo N, Atsuo K, Arai-ichinoi N, et al. Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome [J]. Hum Genet, 2015, 134(6): 649-658.
[15] Daniëlle GM Bosch, F Nienke Boonstra, Nicole de Leeuw, et al. Novel genetic causes for cerebral visual impairment [J]. Eur J Hum Genet, 2016, 24(5): 660-665.
[16] 郎长会, 杨莹, 牛雪阳, 等. SLC35A2基因变异相关的先天性糖基化障碍Ⅱ型临床表型特点[J]. 中华儿科杂志, 2020, 58(7): 586-590. LANG Changhui, YANG Ying, NIU Xueyang, et al. Clinical characteristics of SLC35A2 gene variants related congenital disorders of glycosylation type Ⅱ [J]. Zhonghua Er Ke Za Zhi, 2020, 58(7): 586-590.
[17] 田杨,侯池,王秀英,等. SLC35A2基因突变致马凡综合征家系中West综合征患儿1例报告并文献复习[J]. 临床儿科杂志, 2020, 38(4): 302-305. TIAN Yang, HOU Chi, WANG Xiuying, et al. Clinical characteristics analysis of a child with West syndrome caused by SLC35A2 gene mutation in a Marfan syndrome family and literature review[J]. Journal of Clinical Pediatrics, 2020, 38(4): 302-305.
[18] Sim NS, Seo Y, Lim JS, et al. Brain somatic mutations in SLC35A2 cause intractable epilepsy with aberrant N-glycosylation[J]. Neurol Genet, 2018, 4(6): e294. doi: 10.1212/NXG.0000000000000294.
[19] Hudson HF, Eklund E A, Bobby GN, et al. Neurology of inherited glycosylation disorders [J]. Lancet Neurol, 2012, 11(5): 453-466.
[1] GE Li-Juan, JIN Rui-Feng, WANG Ji-Wen, HU Xin-Sheng, LIKun. Association between the C1236T polymorphism in multi-drug resistance gene 1 and response to antiepileptic drug treatment in epileptic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 99-102.
[2] LI JUN, LI Baomin, YANG LU. Clinical characteristics and genetic analysis of early onset epileptic encephalopathy induced by UBA5 gene mutation [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 58-62.
[3] SONG Luoqing, ZHOU Guoyu, YE Xiang, LU Mei, ZHAO Xinjing. A case report of misdiagnosed cerebral amyloid angiopathy-related inflammation and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 119-122.
[4] PAN Pengfei, XU Lisheng, JI Kunqian, WANG Dexiang, LI Yu. Mitochondrial myopathy beginning with respiratory failure: one case and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 54-59.
[5] Benkang SHI,Shouzhen CHEN,Sifeng QU,Yong WANG,Lei LIU. Research progress and clinical characteristics of clinical rapidly progressing prostate cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 110-116.
[6] HUANG Xiuli, LIU Bingju, SUN Lifeng. Activated phosphoinositide 3-kinase δ syndrome caused by a mutation in PIK3CD gene: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 107-112.
[7] WANG Zhengyang, XIA Yan, SHI Kaixuan, TAO Kun, WANG Xiaojie. Effects of Trametinib on PAX8 expression in ovarian cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 23-29.
[8] JIA Jianhua, CHEN Si, WU Qianqian, XU Shuo, LI Chao, CHENG Lian, XU Shujun. Efficacy of SEEG-guided radiofrequency thermocoagulation in patients with medically intractable epilepsy [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 80-86.
[9] HU Sicui, SUN Qing, WANG Yibing, SUN Lili, SUI Yanxi, LI Tang. Analysis of CLCNKB gene mutation in two families with Bartter syndrome [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 64-70.
[10] LIU Na, LIU Qiji, MOU Kai, CHENG Cuiyun. A case of syndromic neurodevelopmental disorder caused by heterozygous mutation in EBF3 [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 105-109.
[11] WANG Zhendong, DING Wenwen, FENG Zhihui. Correlation between valproic acid exposure and cancer risk in epileptic population [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 110-117.
[12] SUN Yongfeng, LIU Huizhao, LI Yuhuan, SHI Lei, YUAN Jun, ZHONG Jianwei. Application of ultrasound-guided electrocorticography monitoring in the microsurgical treatment of epilepsy secondary to cerebral arteriovenous malformation [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 60-64.
[13] FENG Alei, DONG Qing, PANG Jiaohui, YIN Jiani, LI Qiang, HAN Junqing, YANG Zhe. Exploring molecular characteristics of esophageal squamous cell carcinoma based on next-generation sequencing [J]. Journal of Shandong University (Health Sciences), 2019, 57(7): 80-85.
[14] DING Tingting, ZOU Dong, LIU Haochen. An analysis of the mutation of MSX1 gene in a non-syndromic tooth agenesis family [J]. Journal of Shandong University (Health Sciences), 2019, 57(4): 97-100.
[15] DOU Chunhui, SHAO Jianhua, DONG Xuebin, ZHANG Ling, CHEN Ping, ZHAO Hongyu, GU Linping, SUN Lin, XIE Jie, WANG Min, WANG Juan, LI Na, LI Fan, LI Daqi. Effect of gene mutation on the clinical efficacy of decitabine for patients with myelodysplastic syndrome [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 42-48.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
[2] HUANG Fei,WANG Huaijing,XING Yi,GAO Wei,LI Yonggang,XING Ziying,LI Zhenzhong. Protective effects of NGF and GM1 on primary sensory neurons in SD rat with sciatic nerve injury[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(4): 332 -335 .
[3] TANG Fang1,2, ZHANG Yingqian3, WANG Zhiqiang4, KANG Dianmin4,
WANG Jiezhen1, XUE Fuzhong1. A 2D minimal spanning tree model of the spatial structures of natural focal disease[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(01): 106 -110 .
[4] LYU Longfei, LI Lin, LI Shuhai, QI Lei, LU Ming, CHENG Chuanle, TIAN Hui. Application of laparoscopic fine needle catheter jejunostomy in minimally invasive McKeown resection of esophageal cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 77 -81 .
[5] SHAO Haigang, WANG Xuan, WANG Qing. Anatomy of the root canal system of mandibular first premolar in population of Shandong Province[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 85 -89 .
[6] JIANG Bao-dong,MA Xiang-xing,WANG Qing,WANG Qian,FENG Xiao-yuan,LI Ke,YU Fu-hua. Imaging parameters of multislice spiral CT venography in cerebral veins[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(11): 1084 -1086 .
[7] ZHU Xiaoli1, GUO Shuling1, SU Lei1, FENG Yuxin2, YUAN Fangshu1. Extraction of total proteins from demodex and qualification of their molecular weights[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 58 -62 .
[8] LI Wei,LI Dao-wei,YE Qian,GAO Shun-cui,JIANG Shu-juan.

Diagnostic value of transbronchial needle aspiration in paratracheal mediastinal lesions

[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(11): 1063 -1065 .
[9] ZHONG Nv-juan1, SONG Yong-mei2, LIU Gengsheng2, XUE Fu-zhong1, LIU Yan-xun1. Construction and application of the Bayes network model in
traditional Chinese medicine elements[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 157 .
[10] WANG Xu-ping,ZHAO Ling,FENG Yu-xin,SHANG Lin-shan,LIU Jin-cheng,. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(6): 564 -567 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd